These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25337559)

  • 1. Ovarian cancer biomarker discovery based on genomic approaches.
    Lee JY; Kim HS; Suh DH; Kim MK; Chung HH; Song YS
    J Cancer Prev; 2013 Dec; 18(4):298-312. PubMed ID: 25337559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.
    Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y
    Expert Rev Proteomics; 2016 Oct; 13(10):905-915. PubMed ID: 27598304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biomarker discovery: current status and future perspectives.
    Mäbert K; Cojoc M; Peitzsch C; Kurth I; Souchelnytskyi S; Dubrovska A
    Int J Radiat Biol; 2014 Aug; 90(8):659-77. PubMed ID: 24524284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of Cadherins Methylation in Ovarian Cancer: a Next Generation Sequencing Approach.
    Chmelarova M; Baranova I; Ruszova E; Laco J; Hrochova K; Dvorakova E; Palicka V
    Pathol Oncol Res; 2019 Oct; 25(4):1457-1465. PubMed ID: 30368729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of ovarian cancer.
    Badgwell D; Bast RC
    Dis Markers; 2007; 23(5-6):397-410. PubMed ID: 18057523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In 2014, can we do better than CA125 in the early detection of ovarian cancer?
    Cohen JG; White M; Cruz A; Farias-Eisner R
    World J Biol Chem; 2014 Aug; 5(3):286-300. PubMed ID: 25225597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-biomarker panel signature as the key to diagnosis of ovarian cancer.
    Muinao T; Deka Boruah HP; Pal M
    Heliyon; 2019 Dec; 5(12):e02826. PubMed ID: 31867451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preclinical natural history of serous ovarian cancer: defining the target for early detection.
    Brown PO; Palmer C
    PLoS Med; 2009 Jul; 6(7):e1000114. PubMed ID: 19636370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.
    Njoku K; Chiasserini D; Jones ER; Barr CE; O'Flynn H; Whetton AD; Crosbie EJ
    Front Oncol; 2020; 10():559016. PubMed ID: 33224875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer biomarkers: a focus on genomic and proteomic findings.
    Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R; Marsigliante S; Maffia M; Lorusso V
    Curr Genomics; 2007 Aug; 8(5):335-42. PubMed ID: 19384429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in protein glycosylation biomarkers for ovarian cancer through mass spectrometry-based approaches.
    Lee J; Park JE; Lee D; Seo N; An HJ
    Expert Rev Mol Diagn; 2024 Apr; 24(4):249-258. PubMed ID: 38112537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.
    Leung F; Diamandis EP; Kulasingam V
    Biomark Med; 2012 Oct; 6(5):613-25. PubMed ID: 23075239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis.
    Locke WJ; Clark SJ
    Breast Cancer Res; 2012 Nov; 14(6):215. PubMed ID: 23168266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
    Krzystyniak J; Ceppi L; Dizon DS; Birrer MJ
    Ann Oncol; 2016 Apr; 27 Suppl 1(Suppl 1):i4-i10. PubMed ID: 27141069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for early detection of ovarian cancer.
    Nguyen L; Cardenas-Goicoechea SJ; Gordon P; Curtin C; Momeni M; Chuang L; Fishman D
    Womens Health (Lond); 2013 Mar; 9(2):171-85; quiz 186-7. PubMed ID: 23477323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.